CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income	$ 347	$ 1,047
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses		50
Depreciation and amortization	$ 420	354
Gains on dispositions of repossessed asset		(515)
Amortization of discounts/premiums on investment securities available-for-sale, net	$ 416	684
Deferred income tax provision	90	172
Net gains on sales of investment securities available-for-sale	(29)	(14)
Increase in cash surrender value of bank-owned life insurance	(233)	(205)
Gains at foreclosure	(13)	(51)
Net gains on sale of OREO	$ (84)	(61)
Contribution of OREO		6
Writedown of OREO	$ 545	235
Net changes in:
Accrued interest receivable and other assets	(2)	278
Other liabilities	1,041	(402)
Net cash provided by operating activities	2,498	1,578
Activity in available for sale securities:
Sales	19,860	1,470
Maturities and calls	28,660	10,965
Principal collections	8,215	13,417
Purchases	(67,883)	(29,683)
Purchases of interest bearing time deposits	$ (4,195)	(2,470)
FHLB stock purchases		(263)
FHLB stock redemptions	$ 3	351
Net decrease in loans	8,876	13,390
Purchases of bank premises and equipment	$ (539)	(281)
Disposal of bank premises and equipment		7
Proceeds from death benefit of bank-owned life insurance policies		201
Purchase of bank-owned life insurance policy	$ (300)	(1,500)
Proceeds from dispositions of repossessed asset		1,107
Proceeds from sales of OREO	$ 1,215	725
Net cash provided by (used in) investing activities	(6,088)	7,436
Cash flows from financing activities:
Net decrease in deposits	(1,160)	(4,067)
Proceeds from other borrowings	357	146
Repayments of other borrowings	(203)	(209)
Cash dividends	(235)	(363)
Net cash used in financing activities	(1,241)	(4,493)
Net increase (decrease) in cash and cash equivalents	(4,831)	4,521
Cash and cash equivalents as of the beginning of the period	33,104	28,583
Cash and cash equivalents as of the end of the period	28,273	33,104
Cash paid during period for:
Interest	$ 698	698
Income Taxes		386
Noncash Transactions:
Loans transferred to OREO	$ 1,358	891
Net unrealized gains (losses) on investment securities available-for-sale, net of deferred income tax	$ (333)	387
Loans transferred to foreclosed assets		3
Accretion of Series B preferred stock issuance costs	$ 2	2
Adjustments related to defined benefit plans, net of deferred income tax expense	$ (133)	$ (630)